A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...
Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...
Winnie Byanyima, from UNAIDS: ‘Lenacapavir is more effective than condoms or PrEP in prevention’
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
LGBTQ Nation on MSN1d
Biden administration adds injectable PrEP requirement for insurance providersThe Biden-Harris administration announced Monday a new requirement for insurance providers to cover injectable PrEP in their ...
Cisgender gay and bisexual men, transgender women, and transgender men remain at higher risk for HIV acquisition.
The U.S Food and Drug Administration ( FDA) has confirmed the availability of lenacapavir, a two-yearly injectable HIV/ADS treatment as early as the summer 2025, a decision made by FDA after the ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
Sweden has surpassed the UNAIDS 95-95-95 targets, with reduced HIV incidence and a steady increase in diagnosed and treated ...
Clarence Peeples is part of a small club in the HIV community. He is using his experiences to help fight the virus among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback